Alkermes (ALKS) Receivables (2011 - 2026)
Alkermes (ALKS) posted Receivables of $456.48 million for Q2 2026, up 28.1% from $356.33 million a year earlier and up 12.0% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Receivables (2011 - 2026) Analysis & Trends
At the end of FY2025, Alkermes' Receivables came in at $399.83 million, down 11.9% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
- In prior years, Alkermes' Receivables was $454.03 million in FY2024 (+4.2%), $435.58 million in FY2023 (+21.0%), $359.97 million in FY2022 (-18.3%) and $440.79 million in FY2021 (+14.2%).
- The Q2 2026 figure stands as the highest quarterly Receivables in data going back to Q1 2013.
- On a year-over-year basis, Receivables increased in five of the last eight quarters, with growth averaging 7.5%.
- The strongest year-over-year quarter for Receivables in the past five years was Q2 2026, with growth of 28.1%; the weakest was Q2 2022, with a decline of 14.3%.
- According to Business Quant data, Receivables for the three prior quarters was $407.63 million (Q1 2026), $334.03 million (Q4 2025) and $355.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn | 456.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 456.48 Mn |
| Mar 31, 2026 | 407.63 Mn |
| Dec 31, 2025 | 334.03 Mn |
| Sep 30, 2025 | 355.11 Mn |
| Jun 30, 2025 | 356.33 Mn |
| Mar 31, 2025 | 321.75 Mn |
| Dec 31, 2024 | 389.52 Mn |
| Sep 30, 2024 | 370.18 Mn |
| Jun 30, 2024 | 369.91 Mn |
| Mar 31, 2024 | 317.08 Mn |
| Dec 31, 2023 | 333.18 Mn |
| Sep 30, 2023 | 340.46 Mn |
| Jun 30, 2023 | 334.48 Mn |
| Mar 31, 2023 | 277.61 Mn |
| Dec 31, 2022 | 296.90 Mn |
| Sep 30, 2022 | 267.28 Mn |
| Jun 30, 2022 | 262.33 Mn |
| Mar 31, 2022 | 270.15 Mn |
| Dec 31, 2021 | 326.56 Mn |
| Sep 30, 2021 | 292.67 Mn |
API Access
Alkermes Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();